Abstract
We employ diffuse optical tomography (DOT) to track treatment progress in a female subject presenting with locally advanced invasive carcinoma of the breast during neoadjuvant chemotherapy. Three-dimensional images of total hemoglobin concentration and scattering identified the tumor. Our measurements reveal tumor shrinkage during the course of chemotherapy, in reasonable agreement with magnetic resonance images of the same subject. A decrease in total hemoglobin concentration contrast between tumor and normal tissue was also observed over time. The results demonstrate the potential of DOT for measuring physiological parameters of breast lesions during chemotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1128-1139 |
| Number of pages | 12 |
| Journal | Medical Physics |
| Volume | 32 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2005 |
Bibliographical note
Funding Information:The authors thank J. P. Culver for his work on the instrumentation and for helpful discussions. The authors also thank L. Sherman for her contribution as clinical research assistant and Y. K. Choe for his help with illustrations. This research was supported by NIH R01-CA75124-04 and CALGB150007/150012.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Breast cancer
- Breast imaging
- Diffuse optical tomography
- Near infrared imaging
- Neoadjuvant chemotherapy
Fingerprint
Dive into the research topics of 'Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: A case study with comparison to MRI'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver